Eight promising start-ups present at the next Swiss Venture Day

At the 39th Swiss Venture Day for the first time eight companies will present to VCs and business angels. The reason is the large number of applicants. The event will not be longer than usual so the presentations and the Q&A sessions will be shorter.

The event takes place at the SWX Swiss Exchange, Zurich, on 5 December in the afternoon. Registration on the website of CTI Invest. Registration deadline is 1 December.

Presenting Companies in alphabetical order:
Ability has developed a technology that enables a clinic to train patients with serious walking limitations in highly physiological walking movements with reasonable costs and effort.
Elmove develops and produces powerful and perfect to control power trains for the electric propulsion of two and three wheel vehicles.
Leman Micro Devices is a stealth-mode start-up based in the Lac Leman area of Switzerland, focused on creating exciting new technology for future Smartphones.
Newscron aims to become the Europe’s leading news aggregator.
Numab is a Swiss biotech company that innovates and develops antibody-based therapeutics.
Qvanteq is developing novel stent technologies to address and overcome these clinical shortcomings.
Sanovation is developing an online chronic pain diary called CatchMyPain which allows the detailed description of pain problems
Visionarity has developed Kelvin, the first awareness program that combines technology and social strategies to engage employees on the habit of switching off devices when they are not in use.
 
 
In the morning another Angel Day will be held. Angel Days are a series of workshops by CTI and CTI Invest for new business angels who evaluate projects or are about to invest in early-stage companies. The event will focus on the topic of board members.